Outcomes of a novel rituximab-based non-myeloablative conditioning regimen for hematopoietic cell transplantation in severe aplastic anemia

Bone Marrow Transplant. 2018 Jun;53(6):795-799. doi: 10.1038/s41409-018-0124-6. Epub 2018 Mar 14.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anemia, Aplastic / drug therapy
  • Anemia, Aplastic / therapy*
  • Female
  • Hematopoietic Stem Cell Transplantation / methods*
  • Humans
  • Male
  • Rituximab / administration & dosage*
  • Transplantation Conditioning / methods*

Substances

  • Rituximab